Communiqués Ainos, Inc.

Actions

AIMD

US00902F4028

Equipement et technologie médicale avancés

Temps réel estimé Cboe BZX 20:34:43 07/10/2026			Varia. 5j.	Varia. 1 janv.
1,235 ^USD	-4,26 %		-3,24 %	-25,07 %

28/09	Ainos, Inc. et Biophoenix Co., Ltd. concluent un accord de licence exclusif à l’échelle mondiale pour Veldona	CI
03/08	Ainos, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Communiqués

30/09	Ainos : Completes VELDONA Technology Transfer, Triggering $600,000 License Payment	PU
30/09	Ainos Completes VELDONA Technology Transfer, Triggering $600,000 License Payment	AQ
29/09	Ainos Completes Delivery of 1,400 AI Nose Systems to ASE Under $2.1 Million, Three-Year Contract	AQ
28/09	Ainos Details Partner-Funded VELDONA Development and Revenue Opportunities, Reinforcing Focus on Chemical Intelligence	AQ
24/09	Ainos and BioPhoenix Sign VELDONA License Agreement, Establishing a Potential $10 Million Collaboration Framework	AQ
16/09	VASRO Research Highlights Ainos' New Order, Semiconductor Commercial Momentum and 1 Billion+ Chemical Dataset	AQ
14/09	Ainos Advances AI Nose into Commercial Deployment in Front-End Semiconductor Manufacturing	AQ
09/09	Ainos Secures Three Japanese Robotics Patents, Advancing Chemical Perception for the Physical AI Era	AQ
19/08	Ainos Launches Atmosphere Engine, Extending Physical AI from Environmental Sensing to Active Environmental Management	AQ
17/08	Ainos Unveils Next-Generation AI Nose, Advancing the Infrastructure for Chemical Intelligence	AQ
13/08	Ainos Surpasses 878 Million Real-World Data Points, Up 43% in 23 Days as 1,400-System AI Nose Semiconductor Deployment Advances	AQ
12/08	Ainos to Showcase Environmental Intelligence for Physical AI at SEMICON Taiwan 2026	AQ
10/08	VASRO Research Highlights Ainos' Progress in Scaling Smell AI Commercialization and Compounding Its Smell ID Dataset	AQ
06/08	Zacks Small-Cap Research Covers Ainos' AI Nose Platform and Expansion of Smell AI Applications	AQ
03/08	Ainos Reports Second Quarter 2026 Results and Highlights Continued AI Nose Execution Across Industrial, Healthcare Infrastructure and Robotics Markets	AQ
21/07	Ainos Expands Smell AI With Growing Real-World Scent Dataset for Physical AI	AQ
22/06	VASRO Research Highlights Ainos' Expansion of Smell AI Into Patient-Level Breath Intelligence	AQ
17/06	Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program	AQ
08/06	Ainos Releases 2026 Mid-Year CEO Letter to Shareholders	AQ
05/06	VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations	AQ
03/06	Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study	AQ
01/06	Ainos Launches Smell AI Study at National Taiwan University Hospital for ER Overcrowding and Respiratory Infection Risk Analysis	AQ
20/05	VASRO Research Highlights Ainos AI Nose Commercialization Progress and Semiconductor Industry Shift Toward AI-Driven Environmental Intelligence	AQ
18/05	Zacks Small-Cap Research Highlights Ainos' Smell AI Commercialization	AQ
13/05	Ainos Reports First Quarter 2026 Financial Results and Highlights Smell AI Execution Across Semiconductors and Healthcare Infrastructure Markets	AQ